Literature DB >> 22771033

BRCA2 localization to the midbody by filamin A regulates cep55 signaling and completion of cytokinesis.

Gourish Mondal1, Matthew Rowley, Lucia Guidugli, Jianmin Wu, Vernon S Pankratz, Fergus J Couch.   

Abstract

Disruption of the BRCA2 tumor suppressor is associated with structural and numerical chromosomal defects. The numerical abnormalities in BRCA2-deficient cells may partly result from aberrations in cell division caused by disruption of BRCA2 during cytokinesis. Here we show that BRCA2 is a component of the midbody that is recruited through an interaction with Filamin A actin-binding protein. At the midbody, BRCA2 influences the recruitment of endosomal sorting complex required for transport (ESCRT)-associated proteins, Alix and Tsg101, and formation of CEP55-Alix and CEP55-Tsg101 complexes during abscission. Disruption of these BRCA2 interactions by cancer-associated mutations results in increased cytokinetic defects but has no effect on BRCA2-dependent homologous recombination repair of DNA damage. These findings identify a specific role for BRCA2 in the regulation of midbody structure and function, separate from DNA damage repair, that may explain in part the whole-chromosomal instability in BRCA2-deficient tumors.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22771033      PMCID: PMC3419138          DOI: 10.1016/j.devcel.2012.05.008

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  31 in total

1.  Essential roles of KIF4 and its binding partner PRC1 in organized central spindle midzone formation.

Authors:  Yasuhiro Kurasawa; William C Earnshaw; Yuko Mochizuki; Naoshi Dohmae; Kazuo Todokoro
Journal:  EMBO J       Date:  2004-08-05       Impact factor: 11.598

2.  Functional evaluation and cancer risk assessment of BRCA2 unclassified variants.

Authors:  Kangjian Wu; Shannon R Hinson; Akihiro Ohashi; Daniel Farrugia; Patricia Wendt; Sean V Tavtigian; Amie Deffenbaugh; David Goldgar; Fergus J Couch
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

Review 3.  The many faces of filamin: a versatile molecular scaffold for cell motility and signalling.

Authors:  Yuanyi Feng; Christopher A Walsh
Journal:  Nat Cell Biol       Date:  2004-11       Impact factor: 28.824

4.  Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2.

Authors:  J Liu; Y Yuan; J Huan; Z Shen
Journal:  Oncogene       Date:  2001-01-18       Impact factor: 9.867

5.  Actin-binding protein requirement for cortical stability and efficient locomotion.

Authors:  C C Cunningham; J B Gorlin; D J Kwiatkowski; J H Hartwig; P A Janmey; H R Byers; T P Stossel
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

6.  BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure.

Authors:  Haijuan Yang; Philip D Jeffrey; Julie Miller; Elspeth Kinnucan; Yutong Sun; Nicolas H Thoma; Ning Zheng; Phang-Lang Chen; Wen-Hwa Lee; Nikola P Pavletich
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

7.  Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2.

Authors:  Matthew J Daniels; Yunmei Wang; Miyoung Lee; Ashok R Venkitaraman
Journal:  Science       Date:  2004-09-16       Impact factor: 47.728

8.  Kinesin-like protein CHO1 is required for the formation of midbody matrix and the completion of cytokinesis in mammalian cells.

Authors:  Jurgita Matuliene; Ryoko Kuriyama
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

9.  A mitotic function for the high-mobility group protein HMG20b regulated by its interaction with the BRC repeats of the BRCA2 tumor suppressor.

Authors:  M Lee; M J Daniels; M J Garnett; A R Venkitaraman
Journal:  Oncogene       Date:  2011-03-14       Impact factor: 9.867

10.  Filamin concentration in cleavage furrow and midbody region: frequency of occurrence compared with that of alpha-actinin and myosin.

Authors:  M H Nunnally; J M D'Angelo; S W Craig
Journal:  J Cell Biol       Date:  1980-10       Impact factor: 10.539

View more
  43 in total

1.  Genome annotation by shotgun inactivation of a native gene in hemizygous cells: application to BRCA2 with implication of hypomorphic variants.

Authors:  Soma Ghosh; Anil K Bhunia; Bogdan C Paun; Samuel F Gilbert; Urmil Dhru; Kalpesh Patel; Scott E Kern
Journal:  Hum Mutat       Date:  2015-02       Impact factor: 4.878

2.  BRCA2 minor transcript lacking exons 4-7 supports viability in mice and may account for survival of humans with a pathogenic biallelic mutation.

Authors:  Eswary Thirthagiri; Kimberly D Klarmann; Anil K Shukla; Eileen Southon; Kajal Biswas; Betty K Martin; Susan Lynn North; Valentin Magidson; Sandra Burkett; Diana C Haines; Kathleen Noer; Roberta Matthai; Lino Tessarollo; Jadranka Loncarek; Jonathan R Keller; Shyam K Sharan
Journal:  Hum Mol Genet       Date:  2016-02-26       Impact factor: 6.150

3.  Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches.

Authors:  Lucia Guidugli; Hermela Shimelis; David L Masica; Vernon S Pankratz; Gary B Lipton; Namit Singh; Chunling Hu; Alvaro N A Monteiro; Noralane M Lindor; David E Goldgar; Rachel Karchin; Edwin S Iversen; Fergus J Couch
Journal:  Am J Hum Genet       Date:  2018-01-25       Impact factor: 11.025

Review 4.  Functional assays for analysis of variants of uncertain significance in BRCA2.

Authors:  Lucia Guidugli; Aura Carreira; Sandrine M Caputo; Asa Ehlen; Alvaro Galli; Alvaro N A Monteiro; Susan L Neuhausen; Thomas V O Hansen; Fergus J Couch; Maaike P G Vreeswijk
Journal:  Hum Mutat       Date:  2013-12-03       Impact factor: 4.878

5.  Integrins promote cytokinesis through the RSK signaling axis.

Authors:  Shomita S Mathew; Bethsaida Nieves; Sharon Sequeira; Savitha Sambandamoorthy; Kevin Pumiglia; Melinda Larsen; Susan E Laflamme
Journal:  J Cell Sci       Date:  2013-11-27       Impact factor: 5.285

Review 6.  Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis.

Authors:  J Jeffery; D Sinha; S Srihari; M Kalimutho; K K Khanna
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

Review 7.  The role of vertebrate nonmuscle Myosin II in development and human disease.

Authors:  Xuefei Ma; Robert S Adelstein
Journal:  Bioarchitecture       Date:  2014-08-06

Review 8.  Fanconi anaemia and cancer: an intricate relationship.

Authors:  Grzegorz Nalepa; D Wade Clapp
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

9.  FANCA safeguards interphase and mitosis during hematopoiesis in vivo.

Authors:  Zahi Abdul-Sater; Donna Cerabona; Elizabeth Sierra Potchanant; Zejin Sun; Rikki Enzor; Ying He; Kent Robertson; W Scott Goebel; Grzegorz Nalepa
Journal:  Exp Hematol       Date:  2015-09-11       Impact factor: 3.084

Review 10.  A comprehensive analysis of BRCA2 gene: focus on mechanistic aspects of its functions, spectrum of deleterious mutations, and therapeutic strategies targeting BRCA2-deficient tumors.

Authors:  Anjali Shailani; Raman Preet Kaur; Anjana Munshi
Journal:  Med Oncol       Date:  2018-01-31       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.